181296-84-4 Usage
Uses
Used in Pharmaceutical Industry:
Omigapil is used as a therapeutic agent for the treatment of muscle degenerative diseases such as muscular dystrophy. It serves to inhibit the activity of 15-lipoxygenase (15-LOX), thereby reducing inflammation and muscle damage, and improving muscle cell function. This application is crucial for the development of new treatments aimed at alleviating the symptoms and progression of muscle degeneration.
Check Digit Verification of cas no
The CAS Registry Mumber 181296-84-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,2,9 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 181296-84:
(8*1)+(7*8)+(6*1)+(5*2)+(4*9)+(3*6)+(2*8)+(1*4)=154
154 % 10 = 4
So 181296-84-4 is a valid CAS Registry Number.
InChI:InChI=1/C19H17NO/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19/h1,4-11,13H,12,14H2,2H3
181296-84-4Relevant articles and documents
COUMPOUNDS MODULATING THE ACTIVITY OF GAPDH AND/OR IAMT
-
Page 38, (2010/02/06)
Novel compounds and their use for modulationof L-Isoaspartyl (D-Aspartyl) 0-Metyltransferase and/or glyceraldehyde-3-phosphate dehydrogenase activity enable the prevention treatment or alleviation of diabetes, autoimmune diseases and neuro-degenerative diseases.. Compounds are of any of the formulae I - IV below:
Anti-neurodegeneratively active 10-aminoaliphatyl-dibenzi ?b,f! oxepines
-
, (2008/06/13)
Base-substituted debenz?b,f!oxepines of formula I STR1 wherein alk is a divalent aliphatic radical, R is an amino group that is unsubstituted or mono- or di-substituted by monovalent aliphatic and/or araliphatic radicals or disubstituted by divalent aliph
